Dow Jones Futures Rise; Will AI Rebound Or Drag Down Market? Tesla, Eli Lilly In Buy Areas
Bears mauled AI stocks, but the Dow Jones and Russell 2000 hit new highs last week. Tesla and Eli Lilly are in buy zones.
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
Coinbase, Robinhood and Circle are expanding into stablecoins, payments and prediction markets, but their latest earnings show how hard it is to escape cry...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse ArticlesBears mauled AI stocks, but the Dow Jones and Russell 2000 hit new highs last week. Tesla and Eli Lilly are in buy zones.
Market concentration has reached levels not seen in decades. The three largest U.S. stocks now represent over 20% of the S&P 500’s total value, and the top...
These two S&P 500 components have been solid performers in 2025 and are likely to continue heading higher in the new year as well.
Wall Street is optimistic about the stock market going into next year on hopes that lower interest rates will lift growth. | Kaynak: finance.yahoo.com
From a recent selloff in the shares of Nvidia Corp., to Oracle Corp.’s plunge after reporting mounting spending on AI, to souring sentiment around a network of companies exposed to OpenAI, signs of sk...
The battle to secure Yahoo Finance's annual Company of the Year award is down to two AI titans: Nvidia and OpenAI. | Kaynak: finance.yahoo.com
While legislative language circulates among all four corners of the talks — industry, White House, Republicans and Democrats — the process is still mid-stride. | Kaynak: www.coindesk.com
Tilray’s stock, and shares of other cannabis companies, soared after reports provided investors hope that President Trump would move to have marijuana reclassified as a much less dangerous drug than i...
The future is bleak for Obamacare premiums as people flee higher insurance costs. | Kaynak: www.marketwatch.com
Biotechs are instead spending their time advancing the kind of smart science that will catch the eye of cash-rich pharmaceutical companies. | Kaynak: www.marketwatch.com
The firm has begun offering stablecoin account funding for U.S. retail clients, joining a growing list of brokerages racing to keep pace with crypto-native rivals. | Kaynak: www.coindesk.com
The firms have obtained conditional approval from the Office of the Comptroller of the Currency to convert into national trust banks. | Kaynak: www.coindesk.com